Home/Filings/4/0001209191-12-007394
4//SEC Filing

Pearson J. Michael 4

Accession 0001209191-12-007394

CIK 0000885590other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 3:58 PM ET

Size

5.4 KB

Accession

0001209191-12-007394

Insider Transaction Report

Form 4
Period: 2012-02-01
Pearson J. Michael
DirectorChief Executive Officer
Transactions
  • Tax Payment

    Common Shares, no par value

    2012-02-0149,5396,094,603 total
Footnotes (2)
  • [F1]This number represents common shares withheld from the issuance of common shares to the Reporting Person to satisfy the tax withholding obligations due upon vesting of Matching Restricted Share Units.
  • [F2]This number represents common shares purchased by the Reporting Person, common shares received upon settlement and/or exercise of previously granted equity awards, as well as other outstanding equity awards that were previously reported in Table 1.

Issuer

Valeant Pharmaceuticals International, Inc.

CIK 0000885590

Entity typeother

Related Parties

1
  • filerCIK 0001426004

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 3:58 PM ET
Size
5.4 KB